Literature DB >> 31496103

The efficacy and safety of nutrient supplements in the treatment of mental disorders: a meta-review of meta-analyses of randomized controlled trials.

Joseph Firth1,2,3, Scott B Teasdale4,5, Kelly Allott3,6, Dan Siskind7,8, Wolfgang Marx9, Jack Cotter10, Nicola Veronese11,12, Felipe Schuch13, Lee Smith14, Marco Solmi15,16, André F Carvalho17,18, Davy Vancampfort19,20, Michael Berk6,9, Brendon Stubbs21,22, Jerome Sarris1,23.   

Abstract

The role of nutrition in mental health is becoming increasingly acknowledged. Along with dietary intake, nutrition can also be obtained from "nutrient supplements", such as polyunsaturated fatty acids (PUFAs), vitamins, minerals, antioxidants, amino acids and pre/probiotic supplements. Recently, a large number of meta-analyses have emerged examining nutrient supplements in the treatment of mental disorders. To produce a meta-review of this top-tier evidence, we identified, synthesized and appraised all meta-analyses of randomized controlled trials (RCTs) reporting on the efficacy and safety of nutrient supplements in common and severe mental disorders. Our systematic search identified 33 meta-analyses of placebo-controlled RCTs, with primary analyses including outcome data from 10,951 individuals. The strongest evidence was found for PUFAs (particularly as eicosapentaenoic acid) as an adjunctive treatment for depression. More nascent evidence suggested that PUFAs may also be beneficial for attention-deficit/hyperactivity disorder, whereas there was no evidence for schizophrenia. Folate-based supplements were widely researched as adjunctive treatments for depression and schizophrenia, with positive effects from RCTs of high-dose methylfolate in major depressive disorder. There was emergent evidence for N-acetylcysteine as a useful adjunctive treatment in mood disorders and schizophrenia. All nutrient supplements had good safety profiles, with no evidence of serious adverse effects or contraindications with psychiatric medications. In conclusion, clinicians should be informed of the nutrient supplements with established efficacy for certain conditions (such as eicosapentaenoic acid in depression), but also made aware of those currently lacking evidentiary support. Future research should aim to determine which individuals may benefit most from evidence-based supplements, to further elucidate the underlying mechanisms.
© 2019 World Psychiatric Association.

Entities:  

Keywords:  N-acetylcysteine; Nutrient supplements; adjunctive treatment; attention-deficit/hyperactivity disorder; depression; eicosapentaenoic acid; methylfolate; omega-3; polyunsaturated fatty acids; schizophrenia; vitamin D

Year:  2019        PMID: 31496103      PMCID: PMC6732706          DOI: 10.1002/wps.20672

Source DB:  PubMed          Journal:  World Psychiatry        ISSN: 1723-8617            Impact factor:   49.548


  107 in total

Review 1.  Can nutrient supplements modify brain function?

Authors:  J D Fernstrom
Journal:  Am J Clin Nutr       Date:  2000-06       Impact factor: 7.045

Review 2.  Folate and neural tube defects.

Authors:  Roy M Pitkin
Journal:  Am J Clin Nutr       Date:  2007-01       Impact factor: 7.045

Review 3.  Wilson's disease.

Authors:  Aftab Ala; Ann P Walker; Keyoumars Ashkan; James S Dooley; Michael L Schilsky
Journal:  Lancet       Date:  2007-02-03       Impact factor: 79.321

Review 4.  Omega-3 fatty acids in inflammation and autoimmune diseases.

Authors:  Artemis P Simopoulos
Journal:  J Am Coll Nutr       Date:  2002-12       Impact factor: 3.169

5.  Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.

Authors:  Eva Lonn; Jackie Bosch; Salim Yusuf; Patrick Sheridan; Janice Pogue; J Malcolm O Arnold; Catherine Ross; Andrew Arnold; Peter Sleight; Jeffrey Probstfield; Gilles R Dagenais
Journal:  JAMA       Date:  2005-03-16       Impact factor: 56.272

Review 6.  N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility.

Authors:  Seetal Dodd; Olivia Dean; David L Copolov; Gin S Malhi; Michael Berk
Journal:  Expert Opin Biol Ther       Date:  2008-12       Impact factor: 4.388

7.  Calcium plus vitamin D supplementation and the risk of colorectal cancer.

Authors:  Jean Wactawski-Wende; Jane Morley Kotchen; Garnet L Anderson; Annlouise R Assaf; Robert L Brunner; Mary Jo O'Sullivan; Karen L Margolis; Judith K Ockene; Lawrence Phillips; Linda Pottern; Ross L Prentice; John Robbins; Thomas E Rohan; Gloria E Sarto; Santosh Sharma; Marcia L Stefanick; Linda Van Horn; Robert B Wallace; Evelyn Whitlock; Tamsen Bassford; Shirley A A Beresford; Henry R Black; Denise E Bonds; Robert G Brzyski; Bette Caan; Rowan T Chlebowski; Barbara Cochrane; Cedric Garland; Margery Gass; Jennifer Hays; Gerardo Heiss; Susan L Hendrix; Barbara V Howard; Judith Hsia; F Allan Hubbell; Rebecca D Jackson; Karen C Johnson; Howard Judd; Charles L Kooperberg; Lewis H Kuller; Andrea Z LaCroix; Dorothy S Lane; Robert D Langer; Norman L Lasser; Cora E Lewis; Marian C Limacher; JoAnn E Manson
Journal:  N Engl J Med       Date:  2006-02-16       Impact factor: 91.245

Review 8.  Is low folate a risk factor for depression? A meta-analysis and exploration of heterogeneity.

Authors:  Simon Gilbody; Tracy Lightfoot; Trevor Sheldon
Journal:  J Epidemiol Community Health       Date:  2007-07       Impact factor: 3.710

9.  The glycine transport inhibitor sarcosine is an NMDA receptor co-agonist that differs from glycine.

Authors:  Hai Xia Zhang; Krzysztof Hyrc; Liu Lin Thio
Journal:  J Physiol       Date:  2009-05-11       Impact factor: 5.182

Review 10.  The role of L-methylfolate in depressive disorders.

Authors:  Andrew Farah
Journal:  CNS Spectr       Date:  2009-01       Impact factor: 3.790

View more
  40 in total

Review 1.  Increasing Nrf2 Activity as a Treatment Approach in Neuropsychiatry.

Authors:  G Morris; A J Walker; K Walder; M Berk; W Marx; A F Carvalho; M Maes; B K Puri
Journal:  Mol Neurobiol       Date:  2021-01-07       Impact factor: 5.590

2.  Nutritional Needs in Mental Healthcare: Study Protocol of a Prospective Analytic Observational Study Assessing Nutritional Status, Eating Behavior and Barriers to Healthy Eating in Psychiatric Inpatients and Outpatients Compared to Healthy Adults.

Authors:  Florian Hotzy; Ladina Risch; Sonja Mötteli
Journal:  Front Psychiatry       Date:  2022-06-14       Impact factor: 5.435

3.  A meta-review of "lifestyle psychiatry": the role of exercise, smoking, diet and sleep in the prevention and treatment of mental disorders.

Authors:  Joseph Firth; Marco Solmi; Robyn E Wootton; Davy Vancampfort; Felipe B Schuch; Erin Hoare; Simon Gilbody; John Torous; Scott B Teasdale; Sarah E Jackson; Lee Smith; Melissa Eaton; Felice N Jacka; Nicola Veronese; Wolfgang Marx; Garcia Ashdown-Franks; Dan Siskind; Jerome Sarris; Simon Rosenbaum; André F Carvalho; Brendon Stubbs
Journal:  World Psychiatry       Date:  2020-10       Impact factor: 49.548

Review 4.  Plant-based Medicines (Phytoceuticals) in the Treatment of Psychiatric Disorders: A Meta-review of Meta-analyses of Randomized Controlled Trials: Les médicaments à base de plantes (phytoceutiques) dans le traitement des troubles psychiatriques: une méta-revue des méta-analyses d'essais randomisés contrôlés.

Authors:  Jerome Sarris; Wolfgang Marx; Melanie M Ashton; Chee H Ng; Nicole Galvao-Coelho; Zahra Ayati; Zhang-Jin Zhang; Siegfried Kasper; Arun Ravindran; Brian H Harvey; Adrian Lopresti; David Mischoulon; Jay Amsterdam; Lakshmi N Yatham; Michael Berk
Journal:  Can J Psychiatry       Date:  2021-02-18       Impact factor: 4.356

5.  The efficacy and safety of bisphosphonate analogs for treatment of osteoporosis after spinal cord injury: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Y Wu; F Wang; Z Zhang
Journal:  Osteoporos Int       Date:  2021-01-02       Impact factor: 4.507

Review 6.  Diet and the Microbiota-Gut-Brain Axis: Sowing the Seeds of Good Mental Health.

Authors:  Kirsten Berding; Klara Vlckova; Wolfgang Marx; Harriet Schellekens; Catherine Stanton; Gerard Clarke; Felice Jacka; Timothy G Dinan; John F Cryan
Journal:  Adv Nutr       Date:  2021-07-30       Impact factor: 8.701

Review 7.  Therapeutic Opportunities for Food Supplements in Neurodegenerative Disease and Depression.

Authors:  Rita Businaro; David Vauzour; Jerome Sarris; Gerald Münch; Erika Gyengesi; Laura Brogelli; Pedro Zuzarte
Journal:  Front Nutr       Date:  2021-05-14

Review 8.  New agents and perspectives in the pharmacological treatment of major depressive disorder.

Authors:  Marsal Sanches; Joao Quevedo; Jair C Soares
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2020-11-05       Impact factor: 5.067

9.  Plasma polyunsaturated fatty acids and mental disorders in adolescence and early adulthood: cross-sectional and longitudinal associations in a general population cohort.

Authors:  David Mongan; Colm Healy; Hannah J Jones; Stan Zammit; Mary Cannon; David R Cotter
Journal:  Transl Psychiatry       Date:  2021-05-31       Impact factor: 6.222

Review 10.  Vitamin D in the time of the coronavirus (COVID-19) pandemic - a clinical review from a public health and public mental health perspective.

Authors:  Ursula Werneke; Fiona Gaughran; David M Taylor
Journal:  Ther Adv Psychopharmacol       Date:  2021-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.